elotuzumab   Click here for help

GtoPdb Ligand ID: 8361

Synonyms: BMS-901608 | Empliciti® | HuLuc63
Approved drug Immunopharmacology Ligand
elotuzumab is an approved drug (FDA (2015), EMA (2016))
Compound class: Antibody
Comment: Elotuzumab is a humanized IgG1 antibody targeting CS1 (SLAMF7) [1-2].
Peptide sequences for elotuzumab are available from its IMGT/mAb-DB record.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2015), EMA (2016))
International Nonproprietary Names Click here for help
INN number INN
9074 elotuzumab
Synonyms Click here for help
BMS-901608 | Empliciti® | HuLuc63
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 291
Other databases
GtoPdb PubChem SID 252166573
Search PubMed clinical trials elotuzumab
Search PubMed titles elotuzumab
Search PubMed titles/abstracts elotuzumab
Wikipedia Elotuzumab